Highlights•OK-432 sclerotherapy for macrocystic lymphangiomas was more effective.•This meta-analysis to verify whether the efficacy of OK-432 was related to classification for the first time.•OK-432 should be used to therapy LMs with a lesion diameter greater than 1 cm.•The classification basis is very important to the effect of sclerotherapy treatment.